BEUDAMED
    FDA Adverse Event Injury Summary report: N

    XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

    MDR report key: 2141775 · Received June 27, 2011

    Report

    Report Number
    2024168-2011-04511
    Event Type
    Injury
    Date Received
    June 27, 2011
    Date of Event
    May 1, 2011
    Report Date
    June 3, 2011
    Manufacturer
    AV-TEMECULA-CT
    Product Code
    NIQ
    PMA / PMN Number
    P070015
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    HEALTH PROFESSIONAL

    Narratives

    Additional Manufacturer Narrative · 1

    (B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE STENT REMAINS IN THE PATIENT. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.

    Additional Manufacturer Narrative · 1

    (B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED HYPERSENSITIVITY AND RENAL FAILURE ARE LISTED IN THE INSTRUCTIONS FOR USE AS KNOWN ADVERSE EVENTS ASSOCIATED WITH CORONARY STENTING. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, COULD NOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING. FOLLOW UP INFORMATION RECEIVED CONFIRMED THAT IN AN EXPERT MEDICAL OPINION, IT WAS CONCLUDED THAT THE ETIOLOGY OF THE ALLERGIC REACTION AND KIDNEY FAILURE WAS ANTI-THROMBOTIC MEDICATION, NOT THE XIENCE V STENT. THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY.

    Description of Event or Problem · 1

    SUBSEQUENT TO THE INITIAL MEDWATCH REPORT, EXPERT MEDICAL OPINION CONCLUDED THAT THE ETIOLOGY OF THE ALLERGIC REACTION AND KIDNEY FAILURE WAS ANTI-THROMBOTIC MEDICATION, NOT THE XIENCE V STENT.

    Description of Event or Problem · 1

    IT WAS REPORTED THAT AFTER A PROCEDURE PERFORMED ON AN UNSPECIFIED DATE, A PATIENT DEVELOPED AN ALLERGIC REACTION THAT PROGRESSED TO KIDNEY FAILURE AFTER IMPLANTATION OF A XIENCE STENT IN AN UNSPECIFIED VESSEL. THOUGH REQUESTED, NO ADDITIONAL INFORMATION HAS BEEN PROVIDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT

    Patients

    Seq Age Sex Outcome Treatment
    1 Other